Artículos por temáticas

Gender and Age Determinants of Psychogenic Movement Disorders: A Clinical Profile of 73 Patients.

Kamble N, Prashantha DK, Jha M, Netravathi M, Reddy YC, Pal PK.

Can J Neurol Sci. 2016 Mar;43(2):268-77. doi: 10.1017/cjn.2015.365.

Motor cortex stimulation for movement disorders.

Cioni B, Tufo T, Bentivoglio A, Trevisi G, Piano C.

J Neurosurg Sci. 2016 Jun;60(2):230-41.

Autoimmune movement disorders.

Mckeon A, Vincent A.

Handb Clin Neurol. 2016;133:301-15. doi: 10.1016/B978-0-444-63432-0.00017-7.

Reversible movement disorders due to toxoplasmosis as initial manifestation of HIV-AIDS, with sequential MR and video imaging.

Reyes AJ, Ramcharan K, Aboh S, Duke N.

BMJ Case Rep. 2016 Jun 16;2016. pii: bcr2016215676. doi: 10.1136/bcr-2016-215676. No abstract available.

Spectrum of Movement Disorders in Mitochondrial Disorders-Reply.

Martikainen MH, Burn DJ, Turnbull DM.

JAMA Neurol. 2016 Oct 1;73(10):1254-1255. doi: 10.1001/jamaneurol.2016.2578. No abstract available.

Clinical Pearls in Tremor and Other Hyperkinetic Movement Disorders.

Weiss HD.

Semin Neurol. 2016 Aug;36(4):335-41. doi: 10.1055/s-0036-1585098.

Management of movement disorders in children - Authors' reply.

Koy A, Lin JP, Sanger TD, Marks WA, Mink JW, Timmermann L.

Lancet Neurol. 2016 Dec;15(13):1302-1303. doi: 10.1016/S1474-4422(16)30284-8. No abstract available.

Functional (psychogenic) movement disorders - Clinical presentations.

Hallett M.

Parkinsonism Relat Disord. 2016 Jan;22 Suppl 1:S149-52. doi: 10.1016/j.parkreldis.2015.08.036. Review.

The Effectiveness of Transcranial Brain Stimulation in Improving Clinical Signs of Hyperkinetic Movement Disorders.

Obeso I, Cerasa A, Quattrone A.

Front Neurosci. 2016 Jan 7;9:486. doi: 10.3389/fnins.2015.00486. Review.

Eye movement disorders are an early manifestation of CACNA1A mutations in children.

Tantsis EM, Gill D, Griffiths L, Gupta S, Lawson J, Maksemous N, Ouvrier R, Riant F, Smith R, Troedson C, Webster R, Menezes MP.

Dev Med Child Neurol. 2016 Jun;58(6):639-44. doi: 10.1111/dmcn.13033.

Chronic Traumatic Encephalopathy and Movement Disorders: Update.

Tarazi A, Tator CH, Tartaglia MC.

Curr Neurol Neurosci Rep. 2016 May;16(5):46. doi: 10.1007/s11910-016-0648-3. Review.

Mental Side Effects of Deep Brain Stimulation (DBS) for Movement Disorders: The Futility of Denial.

Cyron D.

Front Integr Neurosci. 2016 Apr 20;10:17. doi: 10.3389/fnint.2016.00017. No abstract available.

A framework for movement disorders in canine neurology.

Strain GM.

Vet J. 2016 Aug;214:122-3. doi: 10.1016/j.tvjl.2016.06.002. No abstract available.

Movement Disorders Presenting in Childhood.

Kurian MA, Dale RC.

Continuum (Minneap Minn). 2016 Aug;22(4 Movement Disorders):1159-85. doi: 10.1212/CON.0000000000000367.

An original pharmacoepidemiologic - pharmacodynamic method: application to antipsychotic-induced movement disorders.

Nguyen TT, Pariente A, Montastruc JL, Lapeyre-Mestre M, Rousseau V, Rascol O, Bégaud B, Montastruc F.

Br J Clin Pharmacol. 2016 Sep 30. doi: 10.1111/bcp.13145. [Epub ahead of print]